Classically, we view the mammalian host as mounting inflammatory immune responses to clear or contain pathogenic microbial organisms while also inducing regulatory immune responses to allow colonization of the host by commensals. This view has been replaced by the more complex concept that there is no clear delineation between the two ([@bib30]; [@bib37]) and that microorganisms use both inflammatory and regulatory immune pathways to their advantage ([@bib30]). Furthermore, it is becoming increasingly accepted that the type of T~H~ response induced is determined not only by the nature of the pathogen but also by environmental cues, including the characteristics of the tissue ([@bib3]; [@bib23]), its nutritional status ([@bib33]), and the presence or absence of inflammatory signals ([@bib7]).

*Yersinia enterocolitica* is a gram-negative extracellular bacteria, which is pathogenic for humans and rodents. A food-borne pathogen that causes gastrointestinal symptoms ([@bib4]), *Y. enterocolitica* has a tropism for lymphoid tissue, though its main mucosal colonization site is the terminal ileum of the small intestine ([@bib35]). Despite studies suggesting an association of *Y. enterocolitica* infection and the development of inflammatory bowel disease ([@bib29]), uveitis ([@bib34]), and arthritis ([@bib20]), no host--pathogen interactions have been identified. TLR2 (Toll-like receptor 2) is a unique TLR because of its ability to bind with multiple coreceptors such as TLR1, TLR6, TLR10, Dectin-1, CD36, and CD14 and to promote both inflammatory ([@bib2]) and regulatory IL-10 T cell responses in vivo ([@bib6]; [@bib28]). Using *Y. enterocolitica* as a model pathogen, we studied how host--pathogen interactions dictated by the route of infection determine the type of T cell responses induced and required for protective immunity. *Y. enterocolitica* also provides an example of a pathogen using TLR2 to promote both pro- and antiinflammatory immunity and identifies TLR6 and TLR1 as innate receptors that promote tolerogenic IL-10 and proinflammatory IL-17 T cell responses in the intestinal environment, respectively.

RESULTS AND DISCUSSION
======================

TLR1 is critical for controlling mucosal but not systemic *Y. enterocolitica* infection
---------------------------------------------------------------------------------------

We hypothesize that the nature of the immune response induced by TLR2 depends on the partner with which it associates. This hypothesis was based on our finding that TLR2/TLR6 ligands promoted tolerogenic DCs and regulatory IL-10 T cell responses in vitro and in vivo, whereas TLR1 primarily induced IL-12p40 production in DCs in vitro ([@bib6]). However, we were unable to demonstrate a role for TLR1 in vivo, so we sought to reassess the role using *Y. enterocolitica*. Because this species normally infects orally, we administered bacteria via gavage to TLR1^−/−^, TLR6^−/−^, and littermate control (TLR1^+/−^ and TLR6^+/−^) mice ([Fig. 1, A--C](#fig1){ref-type="fig"}). In accordance with a previous study demonstrating that TLR2 is involved during oral *Y. enterocolitica* infection ([@bib31]), we confirmed that TLR2^−/−^ mice had a defect in IL-10 production and a reduced bacterial burden in the mesenteric LNs (MLNs); however, overall mortality was not affected (not depicted). Furthermore, TLR6^−/−^ and TLR1^−/−^ had opposing effects; absence of TLR6 dramatically increased survival ([Fig. 1 A](#fig1){ref-type="fig"}) and decreased bacterial burden ([Fig. 1 B](#fig1){ref-type="fig"}), whereas the absence of TLR1 led to decreased survival ([Fig. 1 A](#fig1){ref-type="fig"}), higher bacterial burden in MLNs ([Fig. 1 B](#fig1){ref-type="fig"}), and faster systemic dissemination ([Fig. 1 C](#fig1){ref-type="fig"}).

![**Dependence on TLR1 is determined by the route of infection.** (A) TLR1^−/−^, TLR6^−/−^, or heterozygous littermate controls (littermates) were infected orally with 10^5^ CFU *Y. enterocolitica* strain 8081 and followed for survival. Data are pooled from three individual experiments (*n* = 5 mice per group for each experiment). Statistical significance was determined by Wilcoxon log-rank test (TLR6^−/−^, P \< 0.001; TLR1^−/−^, P \< 0.01). (B) Bacterial burden in MLNs at 3 d after infection. (C) Bacterial burden in the SPLs of orally infected mice 7 d after infection. (D) Survival curve of TLR1^−/−^, TLR6^−/−^, or littermates infected i.v. with 10^5^ CFU *Y. enterocolitica*. Data are pooled from three individual experiments (*n* = 5 mice per group for each experiment). Statistical significance was determined by Wilcoxon log-rank test (TLR6^−/−^, P \< 0.01). (E) Bacterial burden in the SPL at 3 d after infection. (B, C, and E) Data shown are the mean ± SEM (*n* = 7). (F) Bacterial burden in SPL 5 d after i.v. infection. Data shown are the mean ± SEM (*n* = 6). \*, P \< 0.01; \*\*, P \< 0.001 (unpaired Student's *t* test).](JEM_20112339_Fig1){#fig1}

Our previous work has demonstrated that TLR1 had no impact on the survival of mice during systemic infection with *Yersinia pestis*, the causative agent of bubonic plague ([@bib6]). We sought to test whether this difference was caused by the genetic makeup of the bacteria or by the route of infection. We decided to test the latter possibility first, as the intestinal environment is unique in that it expresses high levels of TGF-β and the vitamin A metabolite retinoic acid (RA). In support of this hypothesis, we found that TLR1^−/−^ mice infected systemically with *Y. enterocolitica* displayed no phenotype as compared with infected littermate controls ([Fig. 1, D--F](#fig1){ref-type="fig"}), even at doses of infection as low as 10^3^ CFU (not depicted). These data demonstrate that TLR1 and TLR6 play opposing roles during oral *Y. enterocolitica* infection. Furthermore, they indicate that the host uses different innate receptors to mount protective immunity against a pathogen depending on the route of infection.

TLR1 is critical for the induction of mucosal T~H~17 and IgA responses but is not involved in the induction of systemic T~H~1 responses during *Y. enterocolitica* infection
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

We next wanted to determine whether the differences we observed in TLR1 involvement were linked to differences in the T~H~ responses induced during oral and systemic *Y. enterocolitica* infection. Cytokine analysis of TLR1^−/−^ mice and littermate controls revealed that T~H~17 polarizing innate cytokines ([Fig. S1](http://www.jem.org/cgi/content/full/jem.20112339/DC1){#supp1} and see [Fig. 3 D](#fig3){ref-type="fig"}) and T~H~17 cell responses ([Fig. 2 A](#fig2){ref-type="fig"}) were dependent on the presence of TLR1 and were selectively induced during mucosal *Y. enterocolitica* infection. In contrast, IL-12p70 (Fig. S1) and T~H~1 responses ([Fig. 2 B](#fig2){ref-type="fig"}) were observed during systemic *Y. enterocolitica* infection and conserved in the absence of TLR1. We have previously shown that IL-10 T cell responses were dependent on TLR6 expression during peripheral infection ([@bib6]), and in this study we demonstrate that TLR6 is also required during oral infection with *Y. enterocolitica* ([Fig. 2, A and B](#fig2){ref-type="fig"}), indicating that TLR6 is a critical innate receptor with tolerogenic properties in and outside of the intestinal environment,

![**TLR1 is important for inducing IL-17--mediated immunity during oral infection.** (A and B) TLR1^−/−^, TLR6^−/−^, and littermates were infected orally (A) or i.v. (B) with 10^5^ CFU *Y. enterocolitica*. 6 d after infection, MLNs (oral) or SPLs (i.v.) were harvested. Intracellular cytokine production was analyzed by flow cytometry; plots are representative of one out of six infected mice. Total cell counts were determined for naive (open circles) or infected (closed circles) mice. \*, P \< 0.05; \*\*, P \< 0.01 (unpaired Student's *t* test). (C and D) Levels of anti-*Yersinia* IgA, IgG1, and IgG2a from TLR1^−/−^ or TLR1^+/−^ mice infected orally (C) or i.v. (D) with 10^5^ CFU *Y. enterocolitica*. Fresh fecal pellets or serum were collected on days 0, 10, and 14, and antibody titers were detected by ELISA. Data are represented as the mean ± SEM and are pooled from two experiments (*n* = 6). (E) The ratio of anti-*Yersinia* IgA, IgG1, and IgG2a from infected TLR1^+/−^ and TLR1^−/−^ mice at day 14. (F) Survival curve of C57BL/6 mice infected orally (squares) or i.v. (circles) with 10^5^ CFU *Y. enterocolitica* and injected i.p. with 100 µg monoclonal anti--IL-17 (open symbols) or isotype control (rat Ig; closed symbols) every other day for 8 d. Data are pooled from two individual experiments (*n* = 10). Statistical significance was determined by Wilcoxon Log-rank test (P = 0.0125, oral; P = 0.8972, i.v.). (G) Fecal antibody levels of IgG1, IgG2a, and IgA in anti--IL-17-- or isotype control--treated mice. Data are the mean ± SEM (*n* = 6) from two independent experiments. \*, P \< 0.01 (paired Student's *t* test). (H) Bacterial burden of orally (squares) or i.v. (circles) infected mice treated with isotype control (closed symbols) or anti--IL-17 (open symbols). MLNs and SPLs were harvested at days 3 and 7, respectively, for oral infections, and both organs were harvested at 7 d for i.v. infection. Data are from two pooled experiments (*n* = 6). \*, P \< 0.01 (paired Student's *t* test). BD, below detection. (A, B, and H) Horizontal bars represent the mean.](JEM_20112339_Fig2){#fig2}

The discovery that T~H~17 cells are important for protection against oral but not systemic infection is in agreement with observations that IL-6^−/−^ mice have a more severe disease after oral ([@bib8]) but not i.v. ([@bib22]) infection with *Y. enterocolitica*. Furthermore, our findings also explain seemingly contradictory studies showing that infection in IL-12p40^−/−^ mice results in increased bacterial burden and dissemination ([@bib14]), whereas administration of bioactive IL-12p70 has no effect in mice orally infected with *Y. enterocolitica* ([@bib1]). Our data also demonstrate that TLR1 is critical for the induction of T~H~17 in response to oral *Y. enterocolitica* infections. IL-17 was previously shown to be induced homeostatically by segmented filamentous bacteria ([@bib16]) in addition to having a critical role in the protection against intestinal bacterial pathogens such as *Citrobacter rodentium* ([@bib21]; [@bib15]). However, the molecular mechanism behind the generation of T~H~17 responses at mucosal surfaces has remained poorly understood to this point. The importance of TLR1 in promoting T~H~17 immunity in response to pathogens other than *Y. enterocolitica* or commensal bacteria remains to be determined.

The type of antibody response to an antigen is linked to the nature of the T~H~ cells induced. In particular, T~H~17 and T~H~1 cells have been shown to promote IgA ([@bib17]) and IgG2a antibody responses, respectively ([@bib32]). In accordance with the T~H~ cells induced ([Fig. 2, A and B](#fig2){ref-type="fig"}), *Yersinia*-specific IgA antibodies were found in the feces of orally infected mice, whereas IgG2a antibodies were prominently found in the serum of systemically infected mice ([Fig. 2, C--E](#fig2){ref-type="fig"}). IgG1 was induced in response to both types of infection. Supporting a role for TLR1 during oral infection in IgA-mediated immunity against *Y. enterocolitica*, TLR1^−/−^ mice did not generate *Yersinia*-specific IgA antibodies ([Fig. 2, C--E](#fig2){ref-type="fig"}). The absence of IgA antibodies was associated with an increase in IgG1 antibodies, whereas IgG2a antibodies overall remained unchanged ([Fig. 2, C--E](#fig2){ref-type="fig"}). As anticipated, absence of TLR1 had no significant effect on the antibody response during systemic infection ([Fig. 2, C--E](#fig2){ref-type="fig"}).

To directly assess the link between T~H~17 responses and protective immunity against *Y. enterocolitica*, we treated mice with a neutralizing antibody against IL-17 or an IgG2a isotype control. Mice receiving neutralizing IL-17 antibody began losing weight earlier (day 2 vs. day 5; not depicted) and had increased mortality (P \< 0.05; [Fig. 2 F](#fig2){ref-type="fig"}). In line with a role for IL-17 in mucosal IgA responses ([@bib17]), mice treated with neutralizing anti--IL-17 antibody had a significant decrease in fecal levels of anti-*Yersinia* IgA antibodies ([Fig. 2 G](#fig2){ref-type="fig"}). Furthermore, anti--IL-17--treated mice also had higher bacterial burden and a more disseminated infection with 2-log more bacteria in the spleen (SPL) 7 d after infection as compared to mice receiving isotype control antibody ([Fig. 2 H](#fig2){ref-type="fig"}). As anticipated, blocking IL-17 had no effect during systemic *Y. enterocolitica* infection ([Fig. 2, F--H](#fig2){ref-type="fig"}). The discovery that *Y. enterocolitica* selectively induces T~H~17-dependent IgA responses during oral infection fits from a teleological perspective given that T~H~17 responses preferentially induce secretory IgA antibodies ([@bib11]; [@bib16]; [@bib17]), which are highly resistant to the proteolytic enzymes present in the intestinal environment because of their secretory component and thus are uniquely capable of neutralizing luminal antigens ([@bib10]; [@bib13]). This strongly emphasizes the importance of the tissue microenvironment in determining which type of T~H~ response is induced.

TLR1-induced IL-6 is critical for mucosal T~H~17 responses
----------------------------------------------------------

Because TLR1 is expressed and functions similarly between mucosal and systemic DCs (unpublished data; [@bib9]) and the conditioning of DCs determines the type of T cell response induced, we hypothesized that intestinal but not SPL DCs would induce T~H~17 cell differentiation when stimulated with *Y. enterocolitica* lysates. A distinctive feature of small intestinal DCs is that they operate in an environment rich in TGF-β and vitamin A and express ALDHA2 (aldehyde dehydrogenase-1 member A2), a retinal dehydrogenase involved in the conversion of retinal into RA ([@bib3]; [@bib33]). Expression of TLR2 on CD4 T cells has been shown to promote T~H~17 cells ([@bib27]). To directly examine the effect of TLR1 deficiency in DCs, we used a co-culture system with wild-type naive CD4 T cells and DCs from TLR1-deficient mice. As anticipated, when stimulated with *Y. enterocolitica* lysates, MLN DCs from TLR1^+/−^ mice induced T~H~17 cells in vitro, whereas SPL DCs induced T~H~1 cell differentiation ([Fig. 3 A](#fig3){ref-type="fig"}). In accordance with a selective role for TLR1 in T~H~17 cell differentiation in vivo ([Fig. 2, A and B](#fig2){ref-type="fig"}), TLR1^−/−^ MLN DCs induced significantly fewer T~H~17 cells than littermate control MLN DCs, whereas no differences were observed for T~H~1 polarization ([Fig. 3 A](#fig3){ref-type="fig"}). We next determined whether RA and/or TGF-β would be sufficient to confer the ability to induce T~H~17 responses to SPL DCs. As anticipated by previous studies showing that under inflammatory conditions RA acquires adjuvant properties and has the ability to promote T~H~1 and T~H~17 responses ([@bib7]; [@bib12]), incubation of SPL DCs with RA significantly promoted T~H~1 and, to a lesser degree, T~H~17 cell differentiation ([Fig. 3 B](#fig3){ref-type="fig"}). When TGF-β was added (reproducing the conditions found in the intestinal environment), T~H~1 polarization was lost and T~H~17 polarization was observed ([Fig. 3 B](#fig3){ref-type="fig"}); however, neutralization of TGF-β in the cultures was able to restore T~H~1 polarization (not depicted). These results emphasize the critical role played by the tissue in determining which type of immune response will be mounted against a given pathogen. It also reaffirms that RA loses its tolerogenic properties under inflammatory conditions and suggests that depending on the level of TGF-β, it may preferentially promote T~H~1 or T~H~17 immunity.

![**TLR1-dependent IL-6 is critical for inducing T~H~17 cells during oral infection.** (A) Levels of IFN-γ and IL-17 from co-cultures of naive SPL CD4^+^ T cells and MLN or SPL DCs from TLR1^+/−^ or TLR1^−/−^ mice stimulated with 10 µg/ml *Y. enterocolitica* lysate (Ye). Data shown are the mean ± SEM (*n* = 5) from two individual experiments. \*, P \< 0.05 (unpaired Student's *t* test). (B) Levels of IFN-γ and IL-17 from co-cultures of SPL DCs and CD4^+^ T cells as described in A but with the addition of 10 µM RA or 2 ng/ml TGF-β and RA. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.05 (unpaired Student's *t* test) compared with *Y. enterocolitica* treated. (C) Levels of IL-6, IL-23, and IL-12p70 from TLR1^+/−^ (open bars) and TLR1^−/−^ (closed bars) SPL DCs treated with *Y. enterocolitica* lysate plus RA, TGF-β, or RA/TGF-β. \*, P \< 0.05; \*\*, P \< 0.01 (unpaired Student's *t* test) comparing TLR1^+/−^ and TLR1^−/−^ for each treatment. (D) Levels of IL-6, IL-23, and IL-12p70 in the MLNs from TLR1^+/−^ or TLR6^−/−^ mice 3 d after infection. \*, P \< 0.05; \*\*, P \< 0.01 (Student's *t* test comparing infected knockouts with infected littermates). (B--D) Data are the pooled mean ± SEM (*n* = 6) from two individual experiments. (E) Total CD4^+^IL-17^+^ cells in MLNs of orally infected mice and total CD4^+^IFN-γ^+^ cells in the SPLs of i.v. infected mice as determined by flow cytometry. Data are pooled from two individual experiments (*n* = 6). Horizontal bars represent the mean. \*, P \< 0.05 (paired Student's *t* test).](JEM_20112339_Fig3){#fig3}

We next assessed the in vitro contribution of TLR1 in the induction of innate cytokines involved in T~H~1 and T~H~17 polarization in the presence of *Y. enterocolitica* lysates ([Fig. 3 C](#fig3){ref-type="fig"}). We found that TLR1 signaling in DCs was involved in the production of IL-6 and IL-23 ([Fig. 3 C](#fig3){ref-type="fig"}) but not TGF-β (not depicted). These results are consistent with observations that TLR1-deficient mice displayed decreased levels of IL-6 and IL-23 ([Fig. 3 D](#fig3){ref-type="fig"}) but normal levels of TGF-β (not depicted) in MLNs 3 d after oral infection. In accordance with the data showing normal T~H~1 responses in TLR1-deficient mice during systemic *Y. enterocolitica* infection ([Fig. 2 B](#fig2){ref-type="fig"}), we found no role for TLR1 in IL-12p70 induction in vivo ([Fig. 3 D](#fig3){ref-type="fig"}). However, the in vitro experiments indicated a possible role for TLR1 in IL-12p70 induction under conditions in which TGF-β was absent ([Fig. 3 C](#fig3){ref-type="fig"}).

Together, these data demonstrate that although TLR1 is important for the induction of IL-6 by DCs, the combinatorial effect of tissue-derived TGF-β and IL-6 is necessary for driving anti-*Yersinia* T~H~17 responses. Finally, having demonstrated that TLR1 was required for induction of IL-6 and for T~H~17 polarization, we also found that IL-6 was required for mucosal T~H~17 but not for peripheral T~H~1 responses during *Y. enterocolitica* infection ([Fig. 3 E](#fig3){ref-type="fig"}).

TLR1 signaling is important for recruitment of DCs during oral infection
------------------------------------------------------------------------

Given that we observed a more drastic and specific role for TLR1 in the induction of T~H~17 responses in vivo than in vitro, we tested whether TLR1 had an additional role in vivo during oral *Y. enterocolitica* infection. Taking into account previous findings demonstrating that TLR2/TLR1 ligands imprint a gut-tropic phenotype on T cells ([@bib36]) and low levels of IL-6 and IL-23 in MLNs of TLR1--deficient mice, we hypothesized that TLR1 may also have an effect on DC migration. In accordance with this hypothesis, mice deficient for TLR1 had a 50% reduction in percentage and total DC number in MLNs compared with littermate control mice ([Fig. 4 A](#fig4){ref-type="fig"}). In contrast, the absence of TLR1 did not affect the number of DCs in the SPLs of i.v. infected mice ([Fig. 4 B](#fig4){ref-type="fig"}). These data suggest that TLR1 controls induction of T~H~17 responses during oral *Y. enterocolitica* infection by inducing IL-6 and Il-23 in DCs and allowing their migration to MLNs. We have preliminary evidence that TLR1 may be capable of regulating the production of chemokines necessary for DC recruitment (not depicted).

![**TLR1 also contributes to trafficking of CD11c^+^ cells during oral but not i.v. infection.** TLR1^+/−^ and TLR1^−/−^ mice were infected with 10^5^ *Y. enterocolitica*. (A) MLNs were harvested 3 d after oral infection, and flow cytometry was performed to examine the percentage (left panels) and total cell number (right panel) of CD11c^+^ cells. Cells were gated on FSC and SSC and CD45. (B) SPLs were harvested 3 d after i.v. infection, and flow cytometry was performed as described in A. Data are pooled from two individual experiments (*n* = 6). Horizontal bars represent the mean. \*, P \< 0.05; \*\*, P \< 0.01 (unpaired Student's *t* test).](JEM_20112339_Fig4){#fig4}

Altogether our study emphasizes that TLR2 is unique in that it possesses dual and opposing immunological functions in the intestinal mucosa when associated with TLR1 or TLR6. Given that TLR2/TRL1 and TLR2/TLR6 ligands are triacylated and diacylated lipopeptides, respectively ([@bib26]; [@bib18]; [@bib19]), there is the intriguing possibility that enzymes involved in their acylation may dictate whether they will act as pro- or antiinflammatory mediators. Alterations in the acylation status of LPS with similar consequences have been reported ([@bib5]; [@bib25]). These observations suggest that by fine-tuning the activity of enzymes mediating acylation, bacteria may have the means to positively or negatively modulate the host immune response, thus allowing for controlled colonization of the host. This is in line with the more general concept that bacteria have evolved ways to promote both pro- and antiinflammatory responses in a concerted manner for their own benefit ([@bib30]).

Our findings also have implications in the field of vaccine development, as these data highlight the importance of accounting for both the type of pathogen and the site of action when selecting an immune response to maximize protection while avoiding collateral tissue damage. In particular, they stress that the route of vaccination is critical in determining the nature of the T~H~ immune response induced. Finally, in line with other studies ([@bib7]; [@bib12]), our observation that RA promotes T~H~1 and T~H~17 cell polarization in vitro in the presence of *Y. enterocolitica* lysates suggests that RA may be a useful adjuvant for vaccines that comprise proinflammatory innate ligands.

MATERIALS AND METHODS
=====================

### Mice.

TLR1^−/−^ and TLR6^−/−^ mice were generously provided by S. Akira (Osaka University, Suita, Osaka, Japan) and then bred to C57BL/6 mice. TLR1^+/−^ and TLR6^+/−^ were used as controls, unless otherwise noted in figure legends. All mice were maintained at the University of Chicago, and all animal experiments were performed in accordance with institutional guidelines following experimental protocol review and approval by the Institutional Biosafety Committee and the Institutional Animal Care and Use Committee.

### Bacterial strains and infection.

*Y. enterocolitica* strain 8081 was grown overnight at 26°C in tryptic soy broth (BD), and the culture was refreshed the next morning for 2 h. Bacterial density was measured by OD at 600 nM and diluted to 10^6^ CFU/ml in sterile PBS. Mice were administered 100 µl by intragastric gavage or i.v. In some experiments, mice were treated i.p. with 100 µg anti--IL-17 or anti-IgG2a (R&D Systems) or 100 µg anti--IL-6 or anti-IgG1 (eBioscience) beginning at the time of infection and then every other day for 5 d as previously described ([@bib24]). Bacterial burden was determined by performing serial dilutions of MLNs or SPLs on tryptic soy agar plates (BD). Plates were grown for 48 h at 26°C.

### *Yersinia*-specific antibody ELISA.

96-well plates were coated overnight at 4°C with 10 µg/ml *Y. enterocolitica* lysate prepared as previously described ([@bib6]). In brief, strain 8081 was grown as described in the previous section. The bacteria was pelleted and reconstituted in 0.5 ml sterile PBS. Silicon beads were added to the bacteria, and the solution was lysed using a BeadBeater (BioSpec) for 5 min. Protein determination was performed on the lysate, and 100 µl lysate was plated to make sure all the bacteria were killed. Fecal samples were prepared by collecting fresh fecal pellets and dissolving in 1 ml lysis buffer containing soybean trypsin. Serum was prepared via terminal bleed of the retroorbital plexus. Undiluted fecal supernatants and serum (diluted 1:2) were added to bacteria-coated plates for 2 h at room temperature. Plates were washed and then incubated with HRP-conjugated anti--mouse IgA (Santa Cruz Biotechnology, Inc.) or rabbit anti--mouse IgG1, rabbit anti--mouse IgG2a, or rabbit anti--mouse IgM followed by anti--rabbit HRP (BD). TMB substrate (Dako) was used for detection, and absorbance was read at 495 nm OD. Antibody titers were detected by ELISA and calculated according to the formula: (OD~450nm~ sample − OD~450nm~ of blank) × serum dilution.

### Flow cytometry.

MLN and SPL cells (0.5--10^6^) were incubated overnight with 10 µg/ml heat-killed *Y. enterocolitica* (HKY) and the next day were stimulated for 2 h with PMA and ionomycin in the presence of Golgi plug (BD). The cells were washed and incubated with anti--mouse FcRII/III (CD16/32 clone 2.4G2; BD) for 15 min at 4°C to prevent nonspecific Fc binding. Cells were washed in PBS with 10% BSA (Sigma-Aldrich) and labeled directly with monoclonal antibodies specific for lymphocyte surface markers CD4 PeCy5 (L3T4; BD), IFN-γ PE (XMG1.2; eBioscience), IL-17 PE (17B7; eBioscience), and IL-10 APC (JES5-16E3; eBioscience) at 4°C for 15 min. For CD11c experiments, MLNs and SPLs were digested as described in In vitro DC and T cell co-cultures. Cells were stained with CD45 APC-Cy7 (3011; BD), CD11c FITC (HL3; BD), CD3e PE (145-2C11; BD), and CD19 PE (ID3; BD). Expression was determined on a FACSCanto flow cytometer (BD) using FlowJo software (Tree Star).

### Detection of cytokines.

MLNs or SPLs were homogenized in 1 ml PBS, and ELISA was performed according to product instructions from BD OptEIA kits (IL-10, IL-12p40, and IL-12p70) and R&D Systems kits (IL-23 and TGF-β).

### In vitro DC and T cell co-cultures.

MLN DCs and SPL DCs were isolated as previously described ([@bib7]). In brief, MLNs or SPLs were dissociated using collagenase IV (Sigma-Aldrich), and monocytes were purified using a density gradient. CD11c^+^ cells were purified using CD11c-microbeads (Miltenyi Biotec). 5 × 10^4^ DCs were stimulated with 10 µg/ml *Y. enterocolitica* lysate generated through sonication, and 10^5^ CD4 T cells were harvested from SPLs of wild-type mice via CD4-positive selection (autoMACS; Miltenyi Biotec). Cultures were then stimulated with 10 nM RA or 10 nM RA plus 2 ng/ml TGF-β and in some experiments 1 µg/ml anti--TGF-β (clone 9016; R&D Systems), and supernatants were analyzed after 48 h for cytokines IFN-γ and IL-17 using ELISA.

### Statistics.

Paired and unpaired Student's *t* tests were used when noted in figure legends. Tests that had an interaction of P \< 0.05 were considered significant. Wilcoxon log-rank test was used for analysis of survival.

### Online supplemental material.

Fig. S1 shows the levels of innate cytokines from TLR1^−/−^, TLR6^−/−^, or littermate control mice infected orally or i.v. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20112339/DC1>.
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